期刊文献+

他克莫司缓释胶囊在肝移植受者中的应用——第17届国际肝移植学会年会侧记

原文传递
导出
摘要 随着每天1次给药的他克莫司(Tac)缓释胶囊(商品名:新普乐可复)的上市,有关它在肝移植受者中的应用情况也日益受到关注。在今年第17届国际肝移植学会(ILTS)年会上,世界各地的移植领域专家就此报告了一系列最新研究结果。
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2011年第9期576-576,共1页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献6

  • 1Dopazo C, Rodriguez R, Llado L, et al. Conversion from Prograf? to Advagraf? in liver transplant. Observational Multieenter Study. ILTS, 2011:261.
  • 2Gaudio MD,Cescon M, Ercolani G, et al. Outcome of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged release tacrolimus (Advagraf) in stable liver transplant recipients: University of Bologna Experience. ILTS,2011:257.
  • 3Baccarani U, DAmbrosi L, Rossetto A, et al. Once daily prolonged released (Advagraf) versus twice daily tacrolimus (Prograf) as primary immunosuppression in liver transplantation. ILTS, 2011:22.
  • 4Tan TJ, Chen CL, Lee WC, et al. Tacrolimus once-daily (Advagraf) versus twice-daily (Prograf) in de novo liver transplantatiom a multicenter randomized phase III study comparing safety and efficacy. ILTS, 2011:453.
  • 5Perrella A, Santaniello W, Campanella L, et al. Impact of once-daily prolonged-release taerolimus on glucose metabolism of patients underwent OLTx compared to twice a day taerolimus treatment. ILTS,2011:65.
  • 6Perrella A, DAntonio A, Perrella O, et al. Impact of once-daily prolonged-release tacrolimus on HCV-specific immune response of patients underwent OLTx compared to twice a day tacrolimus treatment. ILTS, 2011:458.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部